#United States #New York #fundraising #Ovarian Cancer #OCRA

Ovarian Cancer Research Alliance Surpasses Fundraising Goals for 2024

The Ovarian Cancer Research Alliance (OCRA) recently celebrated a significant milestone: in its year-end fundraising campaign for 2024, it exceeded its target of $2 million, marking a pivotal moment in its commitment to fight ovarian and related gynecologic cancers. This achievement not only highlights the generosity of its donors but also reinforces the alliance's dedication to advancing research and supporting patients and families affected by these diseases.

Rallying Community Support

The success of the campaign is attributed to the strong backing from the OCRA community. Audra Moran, President and CEO of OCRA, expressed gratitude for the collective commitment shown by supporters. “This remarkable achievement is a testament to the generosity and dedication of our community,” she stated, emphasizing that the funds raised will facilitate groundbreaking research, broaden patient support services, and investigate innovative approaches, including the potential of artificial intelligence to enhance treatment outcomes for individuals battling ovarian cancer.

Plans for 2025 and Beyond

With the funds secured, OCRA is poised to pursue its ambitious agenda for 2025 which includes several key initiatives:

1. Investment in Groundbreaking Research

OCRA will continue its efforts to fuel significant research initiatives aimed at unearthing new treatments and therapies. In 2024 alone, the organization allocated more than $9.2 million in grants to cutting-edge research projects led by prominent scientists in the field. This funding is crucial for the continued development of safer and more effective treatment options for ovarian cancer patients.

2. Expansion of Genetic Testing and Prevention

Building on the momentum from its successful free genetic testing program, OCRA plans to further extend its prevention initiatives. This expansion will enable more individuals to access vital resources necessary for evaluating and managing their risk of ovarian cancer, thereby fostering a proactive approach in health management.

3. Enhancement of Patient Support Services

The support programs offered by OCRA, such as the Woman to Woman peer mentoring network, Staying Connected Support Series, and the new Steps program, are set to grow. In 2024, over 10,000 individuals benefited from these important resources, and OCRA aims to reach an even wider audience in the coming year. This commitment to comprehensive support underscores the alliance's objective to provide emotional and practical assistance to those impacted by ovarian cancer.

4. Advocacy for Health Equity

OCRA remains dedicated to advocating for improved healthcare policies. The alliance plans to amplify its advocacy efforts, particularly advocating for extended Medicare coverage for genetic testing, addressing treatment disparities, and securing increased federal funding for essential research and educational initiatives.

A Future Free of Ovarian Cancer

As the leading global organization focused on ovarian cancer research and patient support, OCRA is more determined than ever to drive progress that improves lives and outcomes for patients. The recent fundraising success signifies not only a financial milestone but also a renewed commitment to the mission of eradicating ovarian cancer. With the support of its community, OCRA looks forward to continuing its important work into 2025 and beyond, striving for a future where ovarian cancer is no longer a devastating reality for women and families.

Ovarian Cancer Research Alliance (OCRA) stands at the forefront of ovarian cancer innovation and support, embodying hope and dedication in its mission to transform lives through research and advocacy.